DENTSPLY SIRONA Inc (NASDAQ:XRAY) Stake Raised by First Trust Advisors LP

Share on StockTwits

First Trust Advisors LP lifted its position in shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 203.9% during the 1st quarter, HoldingsChannel reports. The fund owned 91,083 shares of the medical instruments supplier’s stock after purchasing an additional 61,111 shares during the period. First Trust Advisors LP’s holdings in DENTSPLY SIRONA were worth $4,517,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of the company. Nomura Asset Management Co. Ltd. boosted its stake in shares of DENTSPLY SIRONA by 0.7% during the 4th quarter. Nomura Asset Management Co. Ltd. now owns 39,575 shares of the medical instruments supplier’s stock worth $1,473,000 after acquiring an additional 268 shares in the last quarter. Advisor Partners LLC boosted its stake in shares of DENTSPLY SIRONA by 3.1% during the 1st quarter. Advisor Partners LLC now owns 10,169 shares of the medical instruments supplier’s stock worth $504,000 after acquiring an additional 304 shares in the last quarter. Biltmore Family Office LLC boosted its stake in shares of DENTSPLY SIRONA by 5.8% during the 1st quarter. Biltmore Family Office LLC now owns 5,715 shares of the medical instruments supplier’s stock worth $284,000 after acquiring an additional 315 shares in the last quarter. Mason Street Advisors LLC boosted its stake in shares of DENTSPLY SIRONA by 1.2% during the 1st quarter. Mason Street Advisors LLC now owns 31,749 shares of the medical instruments supplier’s stock worth $1,574,000 after acquiring an additional 373 shares in the last quarter. Finally, Securian Asset Management Inc boosted its stake in shares of DENTSPLY SIRONA by 1.8% during the 1st quarter. Securian Asset Management Inc now owns 22,714 shares of the medical instruments supplier’s stock worth $1,126,000 after acquiring an additional 400 shares in the last quarter. 91.68% of the stock is currently owned by institutional investors and hedge funds.

XRAY has been the topic of several recent analyst reports. HC Wainwright set a $49.00 target price on shares of DENTSPLY SIRONA and gave the stock a “hold” rating in a research note on Friday, April 5th. Barrington Research raised shares of DENTSPLY SIRONA from a “market perform” rating to an “outperform” rating and set a $63.00 target price on the stock in a research note on Monday, May 6th. William Blair upgraded shares of DENTSPLY SIRONA from a “market perform” rating to an “outperform” rating and set a $56.71 price target for the company in a research report on Monday, March 18th. Robert W. Baird upped their price target on shares of DENTSPLY SIRONA from $42.00 to $50.00 and gave the stock a “neutral” rating in a research report on Monday, March 4th. Finally, Bank of America assumed coverage on shares of DENTSPLY SIRONA in a research report on Monday, March 18th. They set a “buy” rating and a $57.00 price target for the company. Eight investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average target price of $53.62.

XRAY opened at $56.90 on Thursday. DENTSPLY SIRONA Inc has a twelve month low of $33.93 and a twelve month high of $57.71. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.06 and a quick ratio of 1.35. The stock has a market cap of $13.31 billion, a P/E ratio of 28.31, a P/E/G ratio of 2.08 and a beta of 0.95.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings results on Friday, May 3rd. The medical instruments supplier reported $0.49 earnings per share for the quarter, topping the consensus estimate of $0.39 by $0.10. The firm had revenue of $946.20 million during the quarter, compared to the consensus estimate of $925.13 million. DENTSPLY SIRONA had a negative net margin of 26.48% and a positive return on equity of 8.99%. The company’s revenue for the quarter was down 1.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.45 EPS. On average, sell-side analysts expect that DENTSPLY SIRONA Inc will post 2.35 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 12th. Shareholders of record on Friday, June 28th will be issued a $0.0875 dividend. This is an increase from DENTSPLY SIRONA’s previous quarterly dividend of $0.09. The ex-dividend date is Thursday, June 27th. This represents a $0.35 dividend on an annualized basis and a yield of 0.62%. DENTSPLY SIRONA’s dividend payout ratio is presently 17.41%.

In other DENTSPLY SIRONA news, SVP Maureen J. Macinnis sold 54,402 shares of the stock in a transaction dated Thursday, May 9th. The shares were sold at an average price of $55.00, for a total value of $2,992,110.00. Following the completion of the sale, the senior vice president now owns 50,962 shares in the company, valued at approximately $2,802,910. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, SVP Maureen J. Macinnis sold 15,000 shares of the stock in a transaction dated Monday, June 10th. The shares were sold at an average price of $56.06, for a total transaction of $840,900.00. Following the completion of the sale, the senior vice president now owns 25,360 shares of the company’s stock, valued at approximately $1,421,681.60. The disclosure for this sale can be found here. In the last quarter, insiders acquired 26,417 shares of company stock valued at $1,425,395 and sold 138,922 shares valued at $7,631,805. 0.62% of the stock is currently owned by corporate insiders.

TRADEMARK VIOLATION WARNING: This news story was reported by Zolmax and is the sole property of of Zolmax. If you are accessing this news story on another website, it was illegally copied and reposted in violation of US and international trademark & copyright laws. The original version of this news story can be viewed at https://zolmax.com/investing/dentsply-sirona-inc-nasdaqxray-stake-raised-by-first-trust-advisors-lp/3112717.html.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

See Also: What does cost of debt say about a company’s financial health?

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc (NASDAQ:XRAY).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

L & S Advisors Inc Sells 105 Shares of Amgen, Inc.
L & S Advisors Inc Sells 105 Shares of Amgen, Inc.
ORBCOMM Inc  CFO Purchases $78,750.00 in Stock
ORBCOMM Inc CFO Purchases $78,750.00 in Stock
24,250 Shares in Centene Corp  Purchased by Compton Capital Management Inc. RI
24,250 Shares in Centene Corp Purchased by Compton Capital Management Inc. RI
Compton Capital Management Inc. RI Sells 1,500 Shares of Morgan Stanley
Compton Capital Management Inc. RI Sells 1,500 Shares of Morgan Stanley
Earnest Partners LLC Acquires 14,667 Shares of Eastman Chemical
Earnest Partners LLC Acquires 14,667 Shares of Eastman Chemical
MFS California Municipal Fund  Stock Price Passes Above 50-Day Moving Average of $0.00
MFS California Municipal Fund Stock Price Passes Above 50-Day Moving Average of $0.00


 
© 2006-2019 Zolmax.